Linkedin Facebook Contact with Pharma Industrial India
 

Last edition

january-february, 2024
All magazines
Subscribe to our magazine
autodoc
 
Home › News › Regulation

US FDA Conducts GMP Inspection at Piramal Pharma's Digwal Facility

US FDA Conducts GMP Inspection at Piramal Pharma's Digwal Facility

The US FDA's Good Manufacturing Practices Inspection of Piramal Pharma Limited's Digwal facility was completed successfully, the company said through an exchange filing.

The inspection that was held from March 27 to 31 was completed successfully with Zero Form-483 observations.

The company in an exchange filing said, "The company is committed to maintaining the highest standards of compliance."

 
Read more on:
More news about: regulation | Published by Manvi | April - 05 - 2023 | 645

Last news about this category

Government Unveils Upgraded Pharmaceuticals Scheme to Boost Industry Standards Government Unveils Upgraded Pharmaceuticals Scheme to Boost Industry Standards
Prime Minister Sets Foundation for Revolutionary Healthcare Project in Nandurbar, Being Executed by Jakson Group Prime Minister Sets Foundation for Revolutionary Healthcare Project in Nandurbar, Being Executed by Jakson Group
Union Minister Launches Nationwide MDA Campaign to Combat Lymphatic Filariasis Union Minister Launches Nationwide MDA Campaign to Combat Lymphatic Filariasis
India's Ministry of Health Revises Pharmaceutical Manufacturing Rules India's Ministry of Health Revises Pharmaceutical Manufacturing Rules
Department of Pharmaceuticals to Launch Scheme for Promotion of Research and Innovation in Pharma-MedTech Sector Department of Pharmaceuticals to Launch Scheme for Promotion of Research and Innovation in Pharma-MedTech Sector
USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma
Gland Pharma Receives EIR From USFDA For Dundigal Facility Gland Pharma Receives EIR From USFDA For Dundigal Facility
Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility
Glenmark Pharma settles drug pricing case with US Department of Justice Glenmark Pharma settles drug pricing case with US Department of Justice
Sun Pharma, Alembic recall drugs in US market Sun Pharma, Alembic recall drugs in US market
 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members

Privacy Policy | Cookies Policy